dr. mesa on the emergence of jak inhibitors in myelofibrosis
Published 3 years ago • 79 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:14
dr. mesa on the safety profiles of jak inhibitors in myelofibrosis
-
0:58
dr. mesa on challenges with jak inhibitors in myelofibrosis
-
1:54
dr. mesa discusses jak inhibitors for myelofibrosis
-
2:22
dr. mesa on the evolving role of jak2 inhibitors in myelofibrosis
-
1:08
dr. mesa on unanswered questions regarding jak inhibitors in myelofibrosis
-
1:42
dr. mesa on jak inhibitors in the pipeline for myelofibrosis
-
1:47
dr. oh on the development of jak inhibitors in myelofibrosis
-
25:13
update on jak inhibitors for myelofibrosis: there is more than one
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
2:43
dr. tefferi on the outlook for jak inhibitors in myelofibrosis
-
1:34:09
jak inhibitors in myelofibrosis: expert insights on cases in personalizing therapy
-
2:03
dr. mesa on jakarta-2 reanalysis for myelofibrosis
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
1:12
dr. mesa on the differences between fedratinib and ruxolitinib in myelofibrosis
-
3:23
myelofibrosis: updates on jak inhibitors
-
19:04
my view on current and future use of jak inhibitors for et, pv, and mf
-
5:34
treating with a jak inhibitor for myelofibrosis
-
1:30
dr. oh discusses the differences between investigational jak inhibitors and ruxolitinib in mpns
-
15:46
the future of jak inhibition in myelofibrosis